Stocks / GSK (LSE: GSK) / LSE:GSK (GSK)About GSKGlaxoSmithKline is one of the worlds leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000. Summary Profile Price History Financials Peer Comparison Share Info Performance Dividends Events GSK (LSE: GSK) Latest News Investing Articles I’d like to buy these 3 bargains for my Stocks and Shares ISA before the FTSE climbs higher 22 March, 2024 | Harvey Jones As the FTSE 100 surges and a host of shares look like ending the week a lot higher, Harvey Jones… Read more » Investing Articles I’d consider buying this FTSE 100 dividend stock before it’s revalued for growth 20 March, 2024 | Kevin Godbold This may be a rare opportunity for me to buy a decent dividend stock with the possibility of a valuation… Read more » Investing Articles 2 last-minute FTSE 100 shares I’m considering buying before the ISA deadline 18 March, 2024 | Royston Wild These FTSE 100 shares could be too cheap to miss, according to our writer Royston Wild. Here's why they're on… Read more » Investing Articles Is GSK’s share price set to soar on a new cancer drug? 13 March, 2024 | Simon Watkins New drugs lines may boost GSK’s share price even further, but even without these, the business looks very undervalued against… Read more » Investing Articles I’m itching to buy these 3 hidden FTSE gems in a Stocks and Shares ISA 25 February, 2024 | Harvey Jones Harvey Jones is keen to add these three FTSE 100 companies to his Stocks and Shares ISA before April. Only… Read more » Investing Articles Despite being around an 18-month high, GSK’s share price looks cheap to me 20 February, 2024 | Simon Watkins GSK’s share price has risen over the past 18 months, but it still looks undervalued against its peers, and new… Read more » Investing Articles Just released: our 3 top income-focused stocks to buy before March [PREMIUM PICKS] 20 February, 2024 | Mark Rogers Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due… Read more » Investing Articles At £16.70, I think this FTSE 100 stock could be 24% undervalued! 19 February, 2024 | Royston Wild The GSK share price offers sector-leading value at current prices. Royston Wild explains why the FTSE 100 stock is on… Read more » Investing Articles 2 contrasting FTSE income stocks investors should consider snapping up! 15 February, 2024 | Sumayya Mansoor Income stocks paying dividends are an enticing prospect. Our writer breaks down two options for investors to take a closer… Read more » Investing Articles £10,000 in savings? I’d aim for £633k in FTSE 100 shares and £25k a year of passive income 13 February, 2024 | Royston Wild I'm aiming for a blistering second income by prioritising investment in FTSE 100 shares. Here's how this strategy could supercharge… Read more » Investing Articles Is the GSK share price too cheap to ignore? 1 February, 2024 | Dylan Hood The GSK share price has risen 7% in 2024, but still looks cheap to me. This Fool takes a closer… Read more » Investing Articles Is biopharmaceutical company GSK worth buying as a high-income dividend stock? 1 February, 2024 | Kevin Godbold The GSK directors are guiding for a dividend rise this year. So does the almost 4% yield make it a… Read more » 123…❯
Investing Articles I’d like to buy these 3 bargains for my Stocks and Shares ISA before the FTSE climbs higher 22 March, 2024 | Harvey Jones As the FTSE 100 surges and a host of shares look like ending the week a lot higher, Harvey Jones… Read more »
Investing Articles I’d consider buying this FTSE 100 dividend stock before it’s revalued for growth 20 March, 2024 | Kevin Godbold This may be a rare opportunity for me to buy a decent dividend stock with the possibility of a valuation… Read more »
Investing Articles 2 last-minute FTSE 100 shares I’m considering buying before the ISA deadline 18 March, 2024 | Royston Wild These FTSE 100 shares could be too cheap to miss, according to our writer Royston Wild. Here's why they're on… Read more »
Investing Articles Is GSK’s share price set to soar on a new cancer drug? 13 March, 2024 | Simon Watkins New drugs lines may boost GSK’s share price even further, but even without these, the business looks very undervalued against… Read more »
Investing Articles I’m itching to buy these 3 hidden FTSE gems in a Stocks and Shares ISA 25 February, 2024 | Harvey Jones Harvey Jones is keen to add these three FTSE 100 companies to his Stocks and Shares ISA before April. Only… Read more »
Investing Articles Despite being around an 18-month high, GSK’s share price looks cheap to me 20 February, 2024 | Simon Watkins GSK’s share price has risen over the past 18 months, but it still looks undervalued against its peers, and new… Read more »
Investing Articles Just released: our 3 top income-focused stocks to buy before March [PREMIUM PICKS] 20 February, 2024 | Mark Rogers Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due… Read more »
Investing Articles At £16.70, I think this FTSE 100 stock could be 24% undervalued! 19 February, 2024 | Royston Wild The GSK share price offers sector-leading value at current prices. Royston Wild explains why the FTSE 100 stock is on… Read more »
Investing Articles 2 contrasting FTSE income stocks investors should consider snapping up! 15 February, 2024 | Sumayya Mansoor Income stocks paying dividends are an enticing prospect. Our writer breaks down two options for investors to take a closer… Read more »
Investing Articles £10,000 in savings? I’d aim for £633k in FTSE 100 shares and £25k a year of passive income 13 February, 2024 | Royston Wild I'm aiming for a blistering second income by prioritising investment in FTSE 100 shares. Here's how this strategy could supercharge… Read more »
Investing Articles Is the GSK share price too cheap to ignore? 1 February, 2024 | Dylan Hood The GSK share price has risen 7% in 2024, but still looks cheap to me. This Fool takes a closer… Read more »
Investing Articles Is biopharmaceutical company GSK worth buying as a high-income dividend stock? 1 February, 2024 | Kevin Godbold The GSK directors are guiding for a dividend rise this year. So does the almost 4% yield make it a… Read more »